Juno Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.04.20	Fred Hutchinson Cancer Research Center -- Moody's assigns A2 to Fred Hutchinson Cancer Research Center's (WA) taxable bonds; outlook stable (Moodys)
14.03.19	Washington Health Care Facilities Auth -- Moody's upgrades Fred Hutchinson Cancer Research Center (WA) to A2 from A3; outlook stable (Moodys)
21.02.18	Celgene Gets Antitrust Clearance For Juno Therapeutics Acquisition (RTTNews)
08.02.18	Celgene Corporation -- Moody's rates Celgene's notes Baa2; stable outlook (Moodys)
24.01.18	WeissLaw LLP Investigates Juno Therapeutics Inc. Acquisition (PR Newswire)
23.01.18	ARRY Shines A BEACON, So Long To JUNO And BIVV, Exciting Time Ahead For GEMP (RTTNews)
22.01.18	SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of Juno Therapeutics, Inc. - JUNO (PR Newswire)
22.01.18	Juno Therapeutics Remains Sharply Higher In Afternoon Trading (RTTNews)
22.01.18	Celgene Corporation -- Moody's affirms Celgene at Baa2; stable outlook (Moodys)
22.01.18	Zweite Übernahme in wenigen Wochen: Celgene kauft Juno Therapeutics (AWP) Der US-Pharmakonzern Celgene bleibt im Kaufrausch.» mehr
22.01.18	Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc. (PR Newswire)
22.01.18	Celgene To Buy Juno Therapeutics In $9 Bln Deal; Reaffirms 2020 Targets (RTTNews)
18.01.18	JUNO Flies On Takeover Rumor, PRTO For Long Haul, SUPN Gaining Strength (RTTNews)
17.01.18	EIGR Disappoints, EXEL's CELESTIAL Excels, JUNO In CELG's Crosshairs? (RTTNews)
13.01.18	JUNO THERAPEUTICS INVESTIGATION BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO (PR Newswire)
05.01.18	Juno Therapeutics Names Cindy Elkins as Chief Information Officer (Businesswire)
03.01.18	Juno Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference (Businesswire)
20.12.17	Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership (PR Newswire)
12.12.17	Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH (Businesswire)
12.12.17	In The Red: ONCE Dims, SYRS On Watch, OVID Waiting For STARS, JUNO Bleeds (RTTNews)
11.12.17	Juno Therapeutics, Celgene Release Additional Data From TRANSCEND Trial (RTTNews)
11.12.17	Juno Therapeutics and Celgene Corporation Release Additional Data from TRANSCEND Trial of JCAR017 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (Businesswire)
09.12.17	Juno Therapeutics Highlights Key Translational Insights with JCAR017 in Patients with DLBCL (Businesswire)
03.12.17	ASH: CLLS Readying For CALM, IMDZ Awaits Data, Can JUNO Magic Continue? (RTTNews)
27.11.17	Juno Therapeutics Appoints Ann L. Lee as Executive Vice President of Technical Operations and Patrick Y. Yang as Executive Vice President, Senior Advisor to the CEO (Businesswire)
06.11.17	Juno Therapeutics to Present at November 2017 Investor Conferences (Businesswire)
03.11.17	DRNA Soars On NASH Deal, JUNO Transcends Expectations, FMI On Solid Footing (RTTNews)
02.11.17	Busy Year Awaits FLKS, Mark Your Calendar For BPMC Data, CLLS Loses Steam (RTTNews)
01.11.17	Juno Therapeutics Reports Third Quarter 2017 Financial Results (Businesswire)
01.11.17	Juno Therapeutics to Highlight New Advances in CD19- and BCMA-Targeted CAR T Therapy at ASH (Businesswire)
31.10.17	JUNO Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of JUNO THERAPEUTICS, INC. (NASDAQ: JUNO) Investors (PR Newswire)
25.10.17	Juno Therapeutics to Report Third Quarter 2017 Financial Results on Wednesday, November 1 (Businesswire)
18.10.17	Trianni and Juno Therapeutics Sign Licensing Agreement for Use of Trianni Transgenic Mouse Platform (PR Newswire)
04.10.17	Lifshitz & Miller LLP Announces Investigation of Foundation Medicine, Inc., Health Insurance Innovations, Inc., Juno Therapeutics, Inc., LendingClub Corporation, MiMedx Group, Inc., Ooma, Inc. (PR Newswire)
22.09.17	IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns (RTTNews)
07.09.17	Technical Snapshots for These Biotech Stocks -- ZIOPHARM Oncology, Zosano Pharma, Juno Therapeutics, and Lexicon Pharma (PR Newswire)
06.09.17	Biotech Stocks Move Higher on New Clinical Trial Developments and Ground-breaking Collaborations (PR Newswire)
06.09.17	Biotech Stocks Move Higher on New Clinical Trial Developments and Ground-breaking Collaborations (PR Newswire)
30.08.17	ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR (RTTNews)
29.08.17	Biotechs Jump on Major Acquisitions, FDA Clearance and Clinical Trial Developments (PR Newswire)
29.08.17	Biotechs Jump on Major Acquisitions, FDA Clearance and Clinical Trial Developments (PR Newswire)
29.08.17	So Long To KITE; JUNO, CLLS, MBIO, BLCM Are Sympathy Plays; PGNX Catches Eye (RTTNews)
28.08.17	Options Trader Alert: Covered-call reports released for Caterpillar Inc., Juno Therapeutics Inc, Kite Pharma, Southwest Airlines Co. and Ulta Salon Cosmetics & Fragrance Inc. (PR Newswire)
19.08.17	JUNO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Juno Therapeutics, Inc. - JUNO (PR Newswire)
15.08.17	Tracking Trends in Biotechnology (PR Newswire)
15.08.17	Tracking Trends in Biotechnology (PR Newswire)
08.08.17	Executives of Juno Therapeutics Under Investigation (PR Newswire)
14.07.17	InvestorsObserver releases covered-call reports for Alibaba, Citigroup, JP Morgan Chase, Juno Therapeutics Inc and Wells Fargo & Co. (PR Newswire)
07.07.17	Daily Technical Summary Reports on Biotech Stocks -- Juno Therapeutics, Lexicon Pharma, NantKwest, and Nektar Therapeutics (PR Newswire)
26.06.17	Biotech Stocks Showing Signs of Resurgence (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Juno Therapeutics Inc

Aktien Top/Flop

Juno Therapeutics Peer Group Nachrichten

Meistgelesene Nachrichten